Delivery Order SPE2DB24D2205-SPE2DB25FDXUB

Award Date 2/3/25
Potential Completion Date 2/4/25
Potential Value $30K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp. The $27,758.87 fixed-price delivery order is for the supply of Descovy 200-25mg tablets, a pharmaceutical product. The contract has an ultimate completion date of December 20, 2024. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that has an Indefinite Delivery Contract (IDC) valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $29,716.08 firm fixed-price delivery order is for the supply of Descovy 200-25 mg tablet, a prescription medication. The contract has an ultimate completion date of November 7, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,322.83 firm fixed-price delivery order covers the supply of Descovy, a pharmaceutical product, with a completion date of February 28, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $17,203.55, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award covers the delivery of Descovy 200-25 mg Tablet, a prescription pharmaceutical product, to support defense and federal healthcare programs. The contract is a Firm Fixed Price Delivery Order, with a completion date of January 14, 2025. The award is not designated under any set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,989.12 firm fixed-price delivery order is for the drug Descovy 200-25 mg tablet, with an ultimate completion date of October 21, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $6,145.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the pharmaceutical product Descovy 200-25 mg tablet, with a completion date of November 18, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $70,182.29 firm fixed-price delivery order is for the supply of DESCOVY 200-25 mg tablets, a specialty medication. The contract has an ultimate completion date of November 15, 2024 and was awarded on November 14, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $6,205.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Descovy 200-25 mg tablets, a medication used in the treatment of HIV. The contract has an ultimate completion date of January 22, 2025 and is a firm fixed-price delivery order. The contract was not designated with a set-aside requirement, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,615.89 firm-fixed price delivery order contract is for the supply of Descovy 200-25 mg tablet, a prescription medication. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, which serves as a primary...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $50,413.75, is for the supply of Descovy 200-25 mg tablets to support federal healthcare programs, particularly military treatment facilities and veterans' healthcare systems. The contract does not have any set-aside designations, indicating open...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FDXUB
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $30,424.54 firm fixed-price delivery order is for the supply of Descovy 200-25 mg Tablet, a medication used in the treatment and prevention of HIV. The contract has an ultimate completion date of February 4, 2025.

AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

Generated 5/5/25, 9:50 AM